Status:
TERMINATED
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Adenomatous Polyposis Coli
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A study to evaluate rofecoxib in the treatment of rectal, colon, or duodenal adenomas in patients with Familial Adenomatous Polyposis.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females at least 18 years of age with familial adenomatous polyposis.
Exclusion
Key Trial Info
Start Date :
August 6 2002
Trial Type :
INTERVENTIONAL
End Date :
October 11 2004
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00140894
Start Date
August 6 2002
End Date
October 11 2004
Last Update
September 20 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.